Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cigna Corp (NY: CI )

343.64 +2.49 (+0.73%)
Official Closing Price Updated: 7:00 PM EDT, Jul 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,135,665
Open 342.69
Bid (Size) 314.50 (1)
Ask (Size) 352.00 (1)
Prev. Close 341.15
Today's Range 342.49 - 346.66
52wk Range 253.95 - 365.71
Shares Outstanding 340,107,539
Dividend Yield 1.43%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Don't overlook NYSE:CI—a stock with solid growth prospects and a reasonable valuation.
THE CIGNA GROUP (NYSE:CI) stands out as a growth opportunity that won't break the bank. 
Via Chartmill
2 Beaten-Down Dividend Stocks With Ultra-High Yields Above 9%: Are They Bargains Now?
Find out if the huge yields these pressured dividend payers offer could be worth the risk. 
Via The Motley Fool

Performance

YTD
+10.82%
+10.82%
1 Month
+1.80%
+1.80%
3 Month
-3.06%
-3.06%
6 Month
+15.39%
+15.39%
1 Year
+17.38%
+17.38%

More News

Read More
Here's How Much You Would Have Made Owning Cigna Group Stock In The Last 20 Years
Via Benzinga
AbbVie Could Soar 24%, According to a Wall Street Analyst. Is the High-Yield Dividend Stock a Buy Now?
Via The Motley Fool
For Healthy Aging, Avoid These Common Obstacles to Good Nutrition
Via StatePoint Media
BofA Downgrades Elevance Health On Medicaid Pressure And Lowered Peer Valuations
Via Benzinga
If You Invested $100 In This Stock 15 Years Ago, You Would Have $1,400 Today
Via Benzinga
Looking Into Cigna Group's Recent Short Interest
Via Benzinga
Healthcare Investors Bet On Easier Medicare Rules Under Potential Trump Administration
Via Benzinga
Topics Government
Exposures Political
Is Big Pharma Poised To Take Over Cannabis? 3 Companies Already Manage 8 In 10 Drug Prescriptions In The US
Via Benzinga
Topics Cannabis
Exposures Cannabis
3 of the Best Stock Buybacks So Far in 2024
Via InvestorPlace
Topics Stocks
Exposures US Equities
FTC Investigation Uncovers Anti-Competitive Practices By Handful Of Pharmacy Benefit Managers, Including CVS Health, UnitedHealth
Via Benzinga
Decoding Cigna Group's Options Activity: What's the Big Picture?
Via Benzinga
What Analysts Are Saying About Cigna Group Stock
Via Benzinga
Here's How Much $1000 Invested In Cigna Group 5 Years Ago Would Be Worth Today
Via Benzinga
When you look at NYSE:CI, it's hard to ignore the strong fundamentals, especially considering its likely undervaluation.
Via Chartmill
Why Walgreens Boots Alliance Plunged in June
Via The Motley Fool
Investors should take note of NYSE:CI, a growth stock that remains attractively priced.
Via Chartmill
Down Over 60%, Is Walgreens Boots Alliance a Bad-News Buy?
Via The Motley Fool
Elevance Stock Elevated On Excellent Marketing Execution
Via Investor's Business Daily
Cigna's Specialty Pharmacy Leadership Expected to Drive Long-Term EPS Growth, Analyst Says
Via Benzinga
Wall Street Favorites: 3 Healthcare Stocks With Strong Buy Ratings for June 2024
Via InvestorPlace
NYSE:CI appears to be flying under the radar despite its strong fundamentals.
Via Chartmill
10 Value Stocks With Low Debt And Strong Growth
Via Talk Markets
Combatting the Loneliness Epidemic: The Role of Muah AI in Providing Emotional Support
Via News Direct
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.